Value based pricing for NHS drugs: an opportunity not to be missed?
AUTOR(ES)
Claxton, Karl
FONTE
BMJ Publishing Group Ltd.
RESUMO
The policy debate about price, value, and innovation in pharmaceuticals is at a critical stage for the NHS. Claxton and colleagues describe the key principles of value based pricing and consider some of the concerns about such a scheme
